Uncomplicated and complicated infections caused by ciprofloxacin sensitive pathogens: Infections of the respiratory tract.
In the treatment of outpatients with pneumonia due to Pneumococcus, ciprofloxacin should not be used as a first choice of drug. Ciprofloxacin can be regarded as an advisable treatment for pneumonias caused by Klebsiella, Enterobacter, Proteus, E.coli, Pseudomonas, Haemophilus, Branhamella, Legionella and Staphylococcus.
Infections of the middle ear (otitis media), of the paranasal sinuses (sinusitis), especially if these are caused by gram negative organisms including Pseudomonas or by Staphylococcus; Infections of the eyes; Infections of the kidneys and/or the efferent urinary tract; Infections of the genital organs, including adnexitis, gonorrhoea, and prostatitis; Infections of the abdominal cavity (e.g. infections of gastrointestinal tract or of the biliary tract, peritonitis); Infections of the skin and soft tissues; Infections of the bones and joints; Sepsis; Infections or imminent risk of infection (prophylaxis) in patients whose immune system has been weakened (e.g. patients on immunosuppressants or have neutropenia); Selective intestinal decontamination in immunocompromised patients.
Inhalation anthrax (post-exposure) in adults and in children: To reduce the incidence or progression of disease following exposure to aerosolised Bacillus anthracis.